Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
11.22
-0.11 (-0.97%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CCRN stock have an average target of 18.75, with a low estimate of 15 and a high estimate of 22. The average target predicts an increase of 67.11% from the current stock price of 11.22.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CCRN stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $17 → $15 | Hold | Maintains | $17 → $15 | +33.69% | Oct 21, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $21 → $19 | Buy | Maintains | $21 → $19 | +69.34% | Aug 8, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +51.52% | Aug 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $24 → $21 | Buy | Maintains | $24 → $21 | +87.17% | May 6, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $21 → $19 | Strong Buy | Maintains | $21 → $19 | +69.34% | May 2, 2024 |
Financial Forecast
Revenue This Year
1.38B
from 2.02B
Decreased by -31.92%
Revenue Next Year
1.33B
from 1.38B
Decreased by -3.64%
EPS This Year
0.53
from 2.05
Decreased by -74.31%
EPS Next Year
0.65
from 0.53
Increased by 23.49%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.4B | 1.4B | 1.4B |
| Avg | 1.4B | 1.3B | 1.4B |
| Low | 1.3B | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -29.5% | 3.2% | 7.5% |
| Avg | -31.9% | -3.6% | 2.8% |
| Low | -34.8% | -11.3% | -3.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.57 | 0.83 | 1.02 |
| Avg | 0.53 | 0.65 | 0.78 |
| Low | 0.47 | 0.37 | 0.50 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -72.3% | 57.5% | 56.6% |
| Avg | -74.3% | 23.5% | 20.0% |
| Low | -77.1% | -29.3% | -23.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.